As a Free StocksGuide user, you can view scores for all 7,018 stocks worldwide.
7 Analysts have issued a TransCode Therapeutics Inc forecast:
7 Analysts have issued a TransCode Therapeutics Inc forecast:
Jun '25 |
+/-
%
|
||
Revenue | - - |
-
|
|
Gross Profit | - - |
-
|
|
EBITDA | -14 -14 |
18%
18%
|
EBIT (Operating Income) EBIT | -15 -15 |
18%
18%
|
Net Profit | -25 -25 |
38%
38%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.
Head office | United States |
CEO | Thomas Fitzgerald |
Employees | 7 |
Founded | 2016 |
Website | www.transcodetherapeutics.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.